(Q45839729)

16 December 2017

title

Infection of B lymphocytes by the human immunodeficiency virus and their susceptibility to cytotoxic cells (English)

1 reference

16 December 2017

0 references

1 reference

Malkovský M

1

1 reference

16 December 2017

Philpott K

2

1 reference

16 December 2017

Dalgleish AG

3

1 reference

16 December 2017

Mellor AL

4

1 reference

16 December 2017

Patterson S

5

1 reference

16 December 2017

Webster AD

6

1 reference

16 December 2017

Edwards AJ

7

1 reference

16 December 2017

Maddon PJ

8

1 reference

16 December 2017

language of work or name

English

0 references

publication date

1 September 1988

1 reference

16 December 2017

European Journal of Immunology

published in

1 reference

16 December 2017

volume

18

1 reference

16 December 2017

page(s)

1315-1321

1 reference

16 December 2017

issue

9

1 reference

16 December 2017

Expression of human alpha-tubulin genes: interspecies conservation of 3' untranslated regions

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180903

Human T-lymphotropic retroviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180903

7 January 2021

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180903

7 January 2021

T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180903

7 January 2021

T4 positive human neoplastic cell lines susceptible to and permissive for HTLV-III

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180903

7 January 2021

Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180903

7 January 2021

The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180903

7 January 2021

HTLV-III infection of EBV-genome-positive B-lymphoid cells with or without detectable T4 antigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180903

7 January 2021

The role of B cell differentiation factors and specific T cell help in the pathogenesis of primary hypogammaglobulinemia

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180903

7 January 2021

Fusion between immunoglobulin-secreting and nonsecreting myeloma cell lines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180903

7 January 2021

Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180903

7 January 2021

Isolation of retroviruses from two patients with "common variable" hypogammaglobulinaemia

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180903

7 January 2021

T-cell-mediated enhancement of host-versus-graft reactivity in mice fed a diet enriched in vitamin A acetate

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180903

7 January 2021

The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobulin gene family.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180903

7 January 2021

Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180903

7 January 2021

Detection of specific sequences among DNA fragments separated by gel electrophoresis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180903

7 January 2021

Genomic diversity of human T-lymphotropic virus type III (HTLV-III).

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180903

7 January 2021

Recombinant interleukin-2 directly augments the cytotoxicity of human monocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180903

7 January 2021

Nonspecific inhibitor released by T acceptor cells reduces the production of interleukin-2.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180903

7 January 2021

Enhancement of specific antitumor immunity in mice fed a diet enriched in vitamin A acetate

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180903

7 January 2021

Acquired immunological tolerance of foreign cells is impaired by recombinant interleukin 2 or vitamin A acetate

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180903

7 January 2021

Susceptibility to infection by the human immunodeficiency virus (HIV) correlates with T4 expression in a parental monocytoid cell line and its subclones

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180903

7 January 2021

Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180903

7 January 2021

Productive, persistent infection of human colorectal cell lines with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180903

7 January 2021

Human immunodeficiency virus induces phosphorylation of its cell surface receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180903

7 January 2021

Adaptation of Lymphadenopathy Associated Virus (LAV) to Replication in EBV-Transformed B Lymphoblastoid Cell Lines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180903

7 January 2021

AIDS-associated retroviruses (ARV) can productively infect other cells besides human T helper cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180903

7 January 2021

Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180903

7 January 2021

HIV and HLA similarity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180903

7 January 2021

Identifiers

DOI

10.1002/EJI.1830180903

1 reference

16 December 2017

PubMed ID

2901961

1 reference

16 December 2017